Qube Research & Technologies (QRT)
QTTB icon

Qube Research & Technologies (QRT)’s Q32 Bio QTTB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,388
Closed -$173K – 3957
2024
Q4 		$173K Buy
+50,388
New +$1.59M ﹤0.01% 2862
2022
Q4 		– Sell
-1,940
Closed -$56K – 3079
2022
Q3 		$56K Sell
1,940
-277
-12% -$11.3K ﹤0.01% 2114
2022
Q2 		$79K Buy
+2,217
New +$75.7K ﹤0.01% 2019

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s QTTB Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 50,388 shares — an estimated $173K sold.

Qube Research & Technologies (QRT) first reported a position in QTTB in Q2 2022 and held it in 3 quarters. The position peaked at $173K in Q4 2024. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 50,388 Q32 Bio shares in Q1 2025, an estimated $173K.
  • Qube Research & Technologies (QRT) first reported a position in Q32 Bio in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Q32 Bio position peaked at $173K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.